split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose
PRO-PanFlu-4001
Approved mab completed
Quick answer
split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose for Influenza is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Influenza
- Phase
- Approved
- Modality
- mab
- Status
- completed